Resources
Explore guides, product overviews & more
Find industry trends, best practices, and expert insights. Learn about Datavant and data logistics for healthcare through our curated collection of materials.
Featured resources
Trial Tokenization: Building a Bridge Between Clinical Trial Data and Real-World Data
Life science companies invest billions of dollars each year researching and developing new treatments for patients. Each of these clinical studies is carefully designed to test specific hypotheses…
Read MoreTrial Tokenization: Building a Bridge Between Clinical Trial Data and Real-World Data
Solving Pharma’s Data Silo Problem: Why a Linkable Data Infrastructure is Good for Biopharma and Good for Patients
Each year, pharmaceutical companies spend billions on the generation and procurement of data. But despite investing heavily in data, pharma companies are limited by the basic problem of…
Read MoreSolving Pharma’s Data Silo Problem: Why a Linkable Data Infrastructure is Good for Biopharma and Good for Patients
Upgrade your HEOR and Demonstrate Value by Leveraging Linked Data
As the healthcare industry moves towards a value-based care model, life sciences companies need to utilize real-world evidence to justify the cost and improve understanding of the effectiveness…
Read MoreUpgrade your HEOR and Demonstrate Value by Leveraging Linked Data
Trial Tokenization and Linking to Real World Data: Extending the effectiveness and safety analysis of a new focal seizure treatment
Recently, a biopharmaceutical company completed at 36 week Phase IV study of 175 patients across 40 trial sites to evaluate the effectiveness and safety of a recently approved…
Read MoreTrial Tokenization and Linking to Real World Data: Extending the effectiveness and safety analysis of a new focal seizure treatment
Profiling and Diagnosing Rare Disease Patients
A pharma client partnered with an Advanced Analytics company to develop a model to identify patients likely to have hereditary ATTR amyloidosis.
Read MoreProfiling and Diagnosing Rare Disease Patients
Overcoming Trial Recruitment Challenges in NASH Using De-identified Patient Linking
Recruiting patients for Nonalcoholic fatty liver disease (NAFLD) and Non-alcoholic steatohepatitis (NASH) trials can be a challenge. Diagnosis and staging require a combination of lab test results combined…
Read MoreOvercoming Trial Recruitment Challenges in NASH Using De-identified Patient Linking
Opening Remarks 2019
Speaker: Senator Tom Daschle, Founder & CEO, The Daschle Group & Former Senate Majority Leader, Steve Swank, Chief Business Officer, Datavant
Read MoreOpening Remarks 2019
How Connected Data Can Be Used to Drive Therapeutic Innovation
Moderated by Vivek Ramaswamy, Speakers: Donna Cryer, Glen de Vries, Jamie MacDonald, Andrew Plump
Read MoreHow Connected Data Can Be Used to Drive Therapeutic Innovation
